Eli Lilly's Foundayo receives UAE approval for type 2 diabetes
The Emirates Drug Establishment gave its consent for Eli Lilly's oral medication Foundayo to be used in adults with type 2 diabetes. This marks the third nation to grant the drug this indication after its earlier clearance for weight management. The once‑daily pill is intended to improve blood‑glucose control while also supporting weight loss. The approval broadens the therapeutic options available to chronic‑disease patients in the region.
Why it matters
The company says the new indication opens a larger market for Foundayo, potentially boosting sales in the Middle East. Analysts note that adding a diabetes indication could increase the drug's revenue contribution in upcoming quarters.
Key facts
- 1The Emirates Drug Establishment approved Foundayo for adults with type 2 diabetes. econotimes.com
- 2The UAE became the third country to authorize Foundayo for this use. econotimes.com
- 3Foundayo had previously received approval in the UAE for weight‑management treatment. tag911.ae
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.